|
|
|
|
Direct Cost |
Indirect Cost |
|
1DP2CA271301-01 |
Uncovering diverse genotype-phenotype relationships in prostate cancer |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$900,000 |
$684,000 |
$1,584,000 |
1F31CA260920-01 |
Elucidating the role of somatic 3’UTR mutations in prostate cancer pathogenesis |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$40,440 |
|
$40,440 |
1F32CA261055-01 |
Autoantibody-based early detection of small-cell lung cancer by immunoimaging |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$65,994 |
|
$65,994 |
1K22CA258805-01 |
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$175,400 |
$14,032 |
$189,432 |
1K23MH126781-01A1 |
Development and Feasibility Testing of a Multi-Component Intervention to Increase HIV Testing and Linkage to Services among MSM in Peru |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIMH |
$175,369 |
$13,600 |
$188,969 |
1K99DE030194-01A1 |
Targeting the DNA Damage Response in HPV+ Head and Neck Cancer |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIDCR |
$150,400 |
$12,032 |
$162,432 |
1K99GM138920-01A1 |
Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$92,592 |
$7,407 |
$99,999 |
1K99GM140251-01 |
Molecular impediments to fate-specifying pioneer factor activity during development |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$90,740 |
$7,259 |
$97,999 |
1R01AI162611-01 |
Fast and flexible Bayesian phylogenetics via modern machine learning |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIAID |
$559,381 |
$237,989 |
$797,370 |
1R01CA249528-01A1 |
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$228,750 |
$173,850 |
$402,600 |
1R01CA255015-01 |
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$228,750 |
$173,850 |
$402,600 |
1R01CA261858-01 |
Rational in situ programming of cancer vaccine-responding T-cell clones |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$306,989 |
$204,531 |
$511,520 |
1R01CA263144-01 |
SALSA - Study of Active Lifestyle Activation |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$457,265 |
$278,719 |
$735,984 |
1R01CA263524-01 |
Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$390,726 |
$296,952 |
$687,678 |
1R01CA264646-01 |
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NCI |
$394,984 |
$239,776 |
$634,760 |
1R01GM139752-01 |
Combined computational and structural studies to create novel macromolecular recognition properties |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$200,000 |
$152,000 |
$352,000 |
1R01GM143186-01 |
Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NIGMS |
$229,786 |
$158,170 |
$387,956 |
1R01HL148189-01A1 |
Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4a |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NHLBI |
$308,680 |
$209,518 |
$518,198 |
1R01HL152439-01A1 |
Integrative Genomics into Genetic Association Studies of Blood Pressure and Stroke in African Americans |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NHLBI |
$373,833 |
$279,840 |
$653,673 |
1R01HL155417-01 |
Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk |
FRED HUTCHINSON CANCER RESEARCH CENTER |
NHLBI |
$268,802 |
$191,204 |
$460,006 |